FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

372489005: Granisetron (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197782010 Granisetron (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211024016 Granisetron en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3196851000005119 granisetron da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Granisetron (substance) Is a 5-HT3 receptor antagonist true Inferred relationship Some
Granisetron (substance) Is a Azabicyclo compound (substance) true Inferred relationship Some
Granisetron (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. 5-HT3 receptor antagonist true Inferred relationship Some
Granisetron (substance) Is a Drug allergen false Inferred relationship Some
Granisetron (substance) Is a Amide true Inferred relationship Some
Granisetron (substance) Is a Indazole (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Granisetron hydrochloride Is a False Granisetron (substance) Inferred relationship Some
Product containing granisetron (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Granisetron (substance) Inferred relationship Some 1
granisetron 1 mg/ml infusionsvæske, koncentrat, ampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Granisetron (substance) Inferred relationship Some
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Granisetron (substance) Inferred relationship Some
granisetron 1 mg/1 ml intravenøs opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Granisetron (substance) Inferred relationship Some
granisetron 200 µg/ml væske til pædiatrisk anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Granisetron (substance) Inferred relationship Some
Granisetron (as granisetron hydrochloride) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Granisetron (substance) Inferred relationship Some
granisetronhydrochlorid 1 mg/1 m l injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Granisetron (substance) Inferred relationship Some
granisetronhydrochlorid 1 mg/1 ml injektionsvæske, opløsning, hætteglas a 4 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Granisetron (substance) Inferred relationship Some
granisetron 0,1 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Granisetron (substance) Inferred relationship Some
Granisetron-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Granisetron (substance) Inferred relationship Some 1
Product containing granisetron in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Granisetron (substance) Inferred relationship Some 1
Granisetron 3.1mg/24hours transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Granisetron (substance) Inferred relationship Some
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Granisetron (substance) Inferred relationship Some 1
Granisetron (as granisetron hydrochloride) 2 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Granisetron (substance) Inferred relationship Some 1
Granisetron hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Granisetron (substance) Inferred relationship Some
Granisetron-containing product in transdermal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron (as granisetron hydrochloride) 200 microgram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron (as granisetron hydrochloride) 3 milligram/3 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Granisetron (substance) Inferred relationship Some 1
Granisetron only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Granisetron (substance) Inferred relationship Some 1
Product containing only granisetron in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Granisetron (substance) Inferred relationship Some 1
Granisetron only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Granisetron (substance) Inferred relationship Some 1
Granisetron only product in transdermal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Granisetron (substance) Inferred relationship Some 1
Granisetron (as granisetron hydrochloride) 1 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Granisetron (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start